This chapter talks about five case studies in bone-related issues in oncology. Increased rates of bone loss are seen in certain cancer treatment settings. Chemotherapy-related ovarian failure, use of aromatase inhibitors (AIs), androgen deprivation therapy (ADT), and steroid use are common risk factors for cancer treatment- induced bone loss. The first case study talks about patients with metastatic disease. Breast, prostate, and lung cancers most commonly metastasize to the bone. The second case study talks about patients undergoing treatment with AIs, ADT, corticosteroids, and chemotherapeutics that lead to gonadal failure with an increased risk of developing osteoporosis. The chapter also presents questions and answers about the bone-related Issues in Oncology.
|Original language||English (US)|
|Title of host publication||Cancer Consult|
|Subtitle of host publication||Expertise for Clinical Practice|
|Number of pages||5|
|State||Published - Jun 20 2014|
All Science Journal Classification (ASJC) codes